Continental Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
FCM
LP
Continental Advisors's AGN Position: Q4 2019 in Review
Continental Advisors sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 16,263 shares — an estimated $2.74M sold.
Continental Advisors first reported a position in AGN in Q1 2016 and held it in 15 quarters. The position peaked at $4.51M in Q3 2018. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.
- Continental Advisors reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
- Continental Advisors sold 16,263 Allergan plc shares in Q4 2019, an estimated $2.74M.
- Continental Advisors first reported a position in Allergan plc in Q1 2016 and held it in 15 quarters.
- Continental Advisors's Allergan plc position peaked at $4.51M in Q3 2018.
- 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.
Based on Continental Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.